Time to remodel the journal impact factor

  title={Time to remodel the journal impact factor},
  • Published 2016
  • Medicine
  • Nature
programmes, and say that they rarely receive responses. Companies that withhold a drug — because it is in short supply or not right for a patient — can find themselves on the receiving end of critical social-media campaigns highlighting individual patients. And firms worry that if a person dies or is harmed while taking a drug, it could hurt the drug's chances of being approved. No one knows how many requests parents make and how often companies approve them, but anecdotally, firms often deny… 

Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps

This review outlines some of the most important issues including research culture, reporting biases, and statistical and methodological issues and proposes three achievable actions which could be implemented to deliver significantly improved transparency and mitigation of bias.

The democratization of scientific publishing

It is argued that trying to publish in top tier journals may not always be the best option and that publishing in indexed, open access journals may expose research to the same or larger audiences.

Assessing scientists for hiring, promotion, and tenure

The content of this paper is hoped to serve as a basis for establishing best practices and redesigning the current approaches to assessing scientists by the many players involved in that process.

Health policy and systems research publications in Latin America warrant the launching of a new specialised regional journal

The growth of publications on HPSR across Latin America and the world is compared and the potential, feasibility and challenges of innovative publication strategies are explored and a vigorous editorial policy focusing on regional and country priorities is supported.

Public participation and the co-production of open scientific knowledge: What is at stake?

It is claimed that the lack of capacities and the interposition of international, biologically-centered research agendas – not access restrictions per se – can hinder the utilization of locally applicable knowledge, deterring public participation in disadvantaged contexts.

The Journal Impact Factor is under attack – use the CAPCI factor instead

It is argued that most, if not all of the misuses of JIF are related to its name, and the word “impact” should be removed, and a new name is proposed, the “CAPCI factor”, standing for Citation Average Per Citable Item, which accurately describes what is represented by this measure.

Journal impact factor: a bumpy ride in an open space

Whether or not the IF should still be considered the gold standard of scholarly assessment in view of the many recent changes and the emergence of new publication models is discussed.

Is the drive for reproducible science having a detrimental effect on what is published?

This paper is a critique of the part played by the reproducible research movement within the scientific community and raises concerns about the strong influence the movement is having on which papers are published through changes to the peer review process.

The Evolving Significance and Future Relevance of the Impact Factor

The impetus to publish in high-IF scientific journals has reached a point where it has become detrimental to science, and editors for the American Society for Microbiology journals have recently decided to remove IF content from their journals’ websites so as to bring the focus back on publishing high-quality science.